# Ursodeoxycholic Acid Attenuates Statin-Induced Impaired Glucose Tolerance

> **NCT06684106** · NA · RECRUITING · sponsor: **First Affiliated Hospital Xi'an Jiaotong University** · enrollment: 128 (estimated)

## Conditions studied

- Hyperlipidemia
- Ursodeoxycholic Acid
- Statin Therapy
- Glucose Intolerance

## Interventions

- **DRUG:** Ursodeoxycholic acid (UDCA) 500 mg
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06684106
- **Lead sponsor:** First Affiliated Hospital Xi'an Jiaotong University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-11-25
- **Primary completion:** 2026-11-11
- **Final completion:** 2027-06-01
- **Target enrollment:** 128 (ESTIMATED)
- **Last updated:** 2025-09-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06684106

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06684106, "Ursodeoxycholic Acid Attenuates Statin-Induced Impaired Glucose Tolerance". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06684106. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*